Shane M. Buker

1.1k total citations
12 papers, 430 citations indexed

About

Shane M. Buker is a scholar working on Molecular Biology, Plant Science and Organic Chemistry. According to data from OpenAlex, Shane M. Buker has authored 12 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Plant Science and 1 paper in Organic Chemistry. Recurrent topics in Shane M. Buker's work include RNA Research and Splicing (5 papers), RNA modifications and cancer (3 papers) and RNA and protein synthesis mechanisms (3 papers). Shane M. Buker is often cited by papers focused on RNA Research and Splicing (5 papers), RNA modifications and cancer (3 papers) and RNA and protein synthesis mechanisms (3 papers). Shane M. Buker collaborates with scholars based in United States, France and Japan. Shane M. Buker's co-authors include Danesh Moazed, Marc Bühler, Serafin U. Colmenares, Mensur Dlakić, Judit Villén, Steven P. Gygi, Robert A. Copeland, P. Ann Boriack‐Sjodin, Tetsushi Iida and Jun‐ichi Nakayama and has published in prestigious journals such as Molecular Cell, Cancer Research and The Plant Journal.

In The Last Decade

Shane M. Buker

10 papers receiving 419 citations

Peers

Shane M. Buker

IMMUN

CTM

Maxim S. Belenikin Russia

Tinne De Cnodder Belgium

Anna Hendrika Cornelia Vlot Germany

Nighat Noureen Pakistan

Karsten Klopffleisch Germany

Liangzhi Luo China

Jindong Zhu China

Jia Lu China

My Hanh Thi Hoang Vietnam

Maxim S. Belenikin Russia

Shane M. Buker

177 ×0.5

196 ×0.9

21 ×0.7

7 ×0.6

IMMUN

7 ×0.6

CTM

Citations per year, relative to Shane M. Buker Shane M. Buker (= 1×) peers Maxim S. Belenikin

Countries citing papers authored by Shane M. Buker

Since Specialization

Citations

This map shows the geographic impact of Shane M. Buker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane M. Buker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane M. Buker more than expected).

Fields of papers citing papers by Shane M. Buker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane M. Buker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane M. Buker. The network helps show where Shane M. Buker may publish in the future.

Co-authorship network of co-authors of Shane M. Buker

This figure shows the co-authorship network connecting the top 25 collaborators of Shane M. Buker. A scholar is included among the top collaborators of Shane M. Buker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane M. Buker. Shane M. Buker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Sparling, Brian A., Hyelee Lee, Simina Grigoriu, et al.. (2025). Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom Replacement. ACS Medicinal Chemistry Letters. 16(11). 2309–2319.

Gotur, Deepali, April Case, Julie Liu, et al.. (2023). Development of assays to support identification and characterization of modulators of DExH-box helicase DHX9. SLAS DISCOVERY. 28(8). 376–384. 2 indexed citations

Daniels, Matthew H., Chuang Lu, David Brennan, et al.. (2023). Abstract 1136: Targeting DHX9 inhibition as a novel therapeutic modality in microsatellite instable colorectal cancer. Cancer Research. 83(7_Supplement). 1136–1136. 2 indexed citations

Buker, Shane M., Stephen J. Blakemore, P. Ann Boriack‐Sjodin, et al.. (2023). Abstract A170: Discovery of small molecule inhibitors of ADAR1. Molecular Cancer Therapeutics. 22(12_Supplement). A170–A170. 2 indexed citations

Buker, Shane M., Zachary A. Gurard‐Levin, Michael D. Scholle, et al.. (2019). A Mass Spectrometric Assay of METTL3/METTL14 Methyltransferase Activity. SLAS DISCOVERY. 25(4). 361–371. 36 indexed citations

Buker, Shane M., P. Ann Boriack‐Sjodin, & Robert A. Copeland. (2019). Enzyme–Inhibitor Interactions and a Simple, Rapid Method for Determining Inhibition Modality. SLAS DISCOVERY. 24(5). 515–522. 31 indexed citations

Boriack‐Sjodin, P. Ann, Alexandra K. Gardino, Thomas A. Wynn, et al.. (2019). Abstract A112: Drug discovery efforts on the RNA protein methyltransferase METTL3/METTL14. Molecular Cancer Therapeutics. 18(12_Supplement). A112–A112. 1 indexed citations

Buker, Shane M. & Mohammad Reza Motamedi. (2011). Purification of Native Argonaute Complexes from the Fission Yeast Schizosaccharomyces pombe. Methods in molecular biology. 725. 1–13.

Colmenares, Serafin U., Shane M. Buker, Marc Bühler, Mensur Dlakić, & Danesh Moazed. (2007). Coupling of Double-Stranded RNA Synthesis and siRNA Generation in Fission Yeast RNAi. Molecular Cell. 27(3). 449–461. 124 indexed citations

10.

Buker, Shane M., Tetsushi Iida, Marc Bühler, et al.. (2007). Two different Argonaute complexes are required for siRNA generation and heterochromatin assembly in fission yeast. Nature Structural & Molecular Biology. 14(3). 200–207. 91 indexed citations

11.

Moazed, Danesh, Marc Bühler, Shane M. Buker, et al.. (2006). Studies on the Mechanism of RNAi-dependent Heterochromatin Assembly. Cold Spring Harbor Symposia on Quantitative Biology. 71(0). 461–471. 31 indexed citations

12.

DiDonato, Raymond J., Erin Arbuckle, Shane M. Buker, et al.. (2004). Arabidopsis ALF4 encodes a nuclear‐localized protein required for lateral root formation. The Plant Journal. 37(3). 340–353. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact